Log In
Print
BCIQ
Print
Print this Print this
 

Vancocin, vancomycin

Also known as: Vancocin Pulvules

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionTricyclic glycopeptide antibiotic
Molecular Target D-alanyl-D-alanine
Mechanism of ActionCell wall synthesis inhibitor
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentMarketed
Standard IndicationDiarrhea (infectious)
Indication DetailsTreat staphylococcal enterocolitis, Clostridium difficile-associated colitis and Clostridium difficile-associated diarrhea (CDAD) infections
Regulatory Designation

Partner

ANI Pharmaceuticals Inc.; ANI Pharmaceuticals Inc.; Merus Labs International Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today